Abstract
In the pharmaceutical production, to control polymorph formation is important from the viewpoint of the productivity and the bioavailability. Anti-solvent or drowning-out crystallization is widely used in the pharmaceutical industry for high yield production. However, anti-solvent addition method to control polymorph formation in anti-solvent crystallization has not been discussed enough. In this study, indomethacin (IMC) which has three polymorphs was used. The purpose of this study is to establish a production method of the target polymorph in the anti-solvent crystallization (IMC–acetone–heptane system). The simulation model for determination of anti-solvent feed rate based on the ternary phase diagram was proposed. The stability of the polymorph of IMC crystal in the solution was changed not only with temperature but also with composition of the mixed solvent. From the experimental and simulation results, the design strategy of anti-solvent crystallization was proposed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
